AbbVie Inc.
ABBV
$159.62
-$7.67-4.59%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
Headlines
4/26/2024
-
Fool.com Headlines
4/26/2024
-
Ticker Report
4/26/2024
-
Fool.com Headlines
4/26/2024
-
Investopedia Headlines
4/26/2024
-
Seeking Alpha - Healthcare
4/26/2024
-
Ticker Report
4/26/2024
-
Seeking Alpha: Transcripts
4/26/2024
-
SeekingAlpha
4/26/2024
-
BizJournals.com - Nat'l Business News
4/26/2024
-
Stock Options Channel
4/26/2024
-
Zacks Investment Research
4/26/2024
-
SeekingAlpha
4/26/2024
-
InvestorPlace
4/26/2024
-
FiercePharma
4/26/2024
-
Seeking Alpha - Healthcare
4/26/2024
-
Quartz
4/26/2024
-
Zacks Investment Research
4/26/2024
-
Yahoo! Finance: News
4/26/2024
-
Seeking Alpha - Healthcare
4/26/2024
-
Zacks Investment Research
4/26/2024
-
Zacks Investment Research
4/26/2024
-
The Fly
4/26/2024
-
The Fly
4/26/2024
-
The Fly
4/26/2024
-
The Fly
Filings
Tuesday, February 20, 2024
Sunday, December 31, 2023
Beginning of May (est)
Price History
Corporate Info
847 932 7900
1 North Waukegan Road
North Chicago, IL 60064-6400
North Chicago, IL 60064-6400
Business Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma...
more